uniQure NV
QUREHealthcare|Biotechnology|Netherlands
$42.63
-1.85 (-4.16%)
Tangible Book
$0.87
About
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
Stock Price
+186.5%(1Y)
Pipeline Summary
11 total trials7
Phase 1
7
Phase 2
0
Phase 3
0
Phase 4
Active: 3Recruiting: 2Completed: 5Withdrawn: 1
Active Trials (5)
Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease
NCT04120493Huntington's Disease
Phase 1Phase 2Active
Enrollment: 43 participants
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
NCT06063850Mesial Temporal Lobe Epilepsy
Phase 1Phase 2Recruiting
Enrollment: 12 participants
Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)
NCT06100276Amyotrophic Lateral Sclerosis
Phase 1Phase 2Active
Enrollment: 20 participants
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
NCT06270316Fabry Disease
Phase 1Phase 2Recruiting
Enrollment: 12 participants
Safety and Efficacy of AMT-130 in European Adults With Early Manifest Huntington's Disease
NCT05243017Huntington Disease
Phase 1Phase 2Active
Enrollment: 14 participants
BioScore
5/10
Watchlist
Ownership
Recent Insider Trades
Kapusta Matthew CSELL
2026-07-0221,082 shares @ $45.16
Abi-Saab WalidSELL
2026-06-3030,000 shares @ $46.42
Kaye JackSELL
2026-06-3021,167 shares @ $46.44
Abi-Saab WalidSELL
2026-06-261,434 shares @ $46.86
Kapusta Matthew CSELL
2026-06-2535,412 shares @ $50.02
Recent News
2026-06-29 10:30:25
2026-06-25 16:35:46
2026-06-24 17:00:34
2026-06-24 13:05:03
2026-06-24 02:25:38
Data last updated: Jul 13, 2026, 12:41 PM